A Dartmouth study finds that molecular hitchhikers living within bacteria can make their hosts extra resistant to medical ...
A novel CRISPR-based technology can spread within bacterial populations to eliminate antibiotic resistance.
Synaffix’s glycan-based antibody–drug conjugate technology is experiencing strong demand, based on its potential to improve safety and efficacy of cancer therapies without genetic engineering.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results